Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Terms and conditions of purchase
The conditions agreed in a purchase agreement with a vendor. This contract may be between customer and retailer or B2B. This contract outlines the rights of buyer and seller with regards the product or services they are entering into. This contract should be made aware to both parties at the POS.
See also:
Point of sale (POS)
Related terms
Product class, Defining Advertising Goals for Measured Advertising Response (DAGMAR), Free market economy, Ansoff Matrix, Product differentiation, Four Ps, Normal distribution, Attitudinal scaling, Cash cow, Global marketing, Growth stage, Opportunity cost, Leader pricing, Long term value (LTV), Personal selling,
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- My body. My choice. Are we all talking about the same thing?
- BeiGene announces positive phase 3 trial results for liver cancer treatment
- Sanofi halts recruitment for trials assessing MS treatment
- Merck and Cerevance to research novel targets in Alzheimer’s disease
- Michael J Fox Foundation awards Koneksa second research grant
- FDA approves Bot Image’s AI software for the detection and diagnosis of prostate cancer
- GSK/Merck KGgA cancer drug fails in third trial
- GSK’s ViiV and Medicines Patent Pool agree deal for HIV prevention
- Avastin wins EU approval for advanced renal cancer
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- Roche shares new positive Ocrevus data for MS patients
